SLC1A5 and non-small cell lung carcinoma: It is now well established that SLC1A5 is upregulated and promotes cancer development in multiple cancers, such as hepatocellular carcinoma (HCC), non-small-cell lung cancer (NSCLC), and gastric cancer (GC) (Lopes et al., 2021).